Moneycontrol
Get App
Last Updated : Aug 22, 2019 12:14 PM IST | Source: Moneycontrol.com

Granules India slips 3% after USFDA flags foreign subsidiary

Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

Moneycontrol News @moneycontrolcom
Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Granules India shed nearly 3 percent intraday on August 22 after the company received 2 observations from USFDA.

United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Virginia, USA on August 21, with two minor observations.

This is a pre-approval inspection for seven products filed from this facility.

Close

Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

At 1155 hrs, Granules India was quoting at Rs 89.60, down Rs 2, or 2.18 percent on the BSE.

The share touched its 52-week high of Rs 123.35 and its 52-week low of Rs 79 on 10 September 2018 and 10 December 2018, respectively.

Currently, it is trading 27.36 percent below its 52-week high and 13.42 percent above its 52-week low.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Aug 22, 2019 12:14 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant